EUVIMEDEUVIMED entdecken
Crossref

The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down Syndrome

Javier García-Alba iD, Elisa M Molanes-López iD, Pilar Zuluaga, Lucía Vaquero, Ricardo Bajo, José A Hinojosa, Rocío Calvillo-Torres, José M Galván-Román, Cristina Bell-Fenellos, Daniel Alcolea, Juan Fortea, Natalia Lagunas und 5 weitere

Journal of Intellectual Disability Research · 2026-08 · 70 (8) · 823-834

DOI: 10.1111/jir.70120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Intellectual Disability Research, online erschienen am 15.05.2026. Verfasst von Javier García-Alba und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology in Education and Research, Complutense University of Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, tau Proteins. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Ministerio de Ciencia e Innovación de España.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The validation of noninvasive markers for the early detection of Alzheimer's disease (AD) in Down syndrome (DS) is a crucial goal within this population. DS patients are characterised by their overall vulnerability and, particularly, by their high risk of developing AD due to genetic conditions. Considering this background, in this study, we analysed the benefits that a combination of markers might yield in such detection.

Methods

Sixty‐two participants (35 females, 27 males) with DS (age > 45 years) distributed in three groups (asymptomatic [A DS ], prodromal [P DS ] and dementia [D DS ]) underwent clinical and neuropsychological evaluation, together with the assessment of brain volumetry, plasma (neurofilament light and p‐tau217), genetic (APOE4) and EEG markers.

Results

Regression analyses demonstrated the key role of p‐tau217 among the studied biomarkers. However, the inclusion of p‐tau217 failed to produce any significant improvement in the diagnostic model based on verbal memory tasks. This model correctly classified 88.0% of the A DS patients, 75.0% of the P DS patients and 93.8% of the D DS patients. In addition, a strong correlation was observed between p‐tau217 , delta power, volumetric scores and memory performance.

Conclusions

Our findings suggested that, even when controlling the effect of elevated p‐tau217 levels, the role of memory markers is essential to assist in AD diagnosis within the DS population. The combination of cognitive and plasma markers for the detection of prodromal AD cases in DS appeared to be highly effective. This is especially relevant after the recent FDA's approval of plasma markers such as ptau‐217 for the diagnosis of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeAlzheimer Diseasetau ProteinsHumansFemaleMaleElectroencephalographyBiomarkersMiddle AgedProdromal SymptomsAgedEarly Diagnosis

Stichwörter der Autor:innen

Alzheimer's diseaseDown syndromeEEG markersbrain volumetryplasma biomarkersp‐tau217

Substanzen

Biomarkerstau ProteinsMAPT protein, human

Autor:innen und Institutionen

  • Department of Psychology in Education and Research, Complutense University of Madrid, Madrid, Spain.
  • Center for Cognitive and Computational Neuroscience (c3n), Cognitive Neuroscience Research Group, Madrid, Spain.
  • Department of Statistics and Operational Research, Complutense University of Madrid, Madrid, Spain.
  • Research Group in Digital Culture and Social Movements & Department of Experimental Psychology, Cognitive Processes and Speech Therapy, Complutense University of Madrid, Madrid, Spain.
  • Music and Audio Research Lab (MARL) & Center for Language Music and Emotion (CLaME), New York University, New York City, New York, USA.
  • Institute of Applied Magnetism, Complutense University of Madrid, Madrid, Spain.

ORCID-Profile: Javier García-Alba, Elisa M Molanes-López

Förderung

  • Ministerio de Ciencia e Innovación de España

Zitieren

APA

García-Alba, J., Molanes-López, E. M., Zuluaga, P., Vaquero, L., Bajo, R., Hinojosa, J. A., Calvillo-Torres, R., Galván-Román, J. M., Bell-Fenellos, C., Alcolea, D., Fortea, J., Lagunas, N., Alfayate, E., García, F., Mateo, G., Modenhauer, F., & Fernández, A. (2026). The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down Syndrome. Journal of Intellectual Disability Research, 70(8), 823-834. https://doi.org/10.1111/jir.70120

Vancouver

García-Alba J, Molanes-López EM, Zuluaga P, Vaquero L, Bajo R, Hinojosa JA, et al. The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down Syndrome. Journal of Intellectual Disability Research. 2026;70(8):823-834. doi:10.1111/jir.70120

BibTeX
@article{GarcaAlba2026,
  author = {García-Alba, Javier and Molanes-López, Elisa M and Zuluaga, Pilar and Vaquero, Lucía and Bajo, Ricardo and Hinojosa, José A and Calvillo-Torres, Rocío and Galván-Román, José M and Bell-Fenellos, Cristina and Alcolea, Daniel and Fortea, Juan and Lagunas, Natalia and Alfayate, Eva and García, Felipe and Mateo, Gloria and Modenhauer, Fernando and Fernández, Alberto},
  title = {The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down Syndrome},
  journal = {Journal of Intellectual Disability Research},
  year = {2026},
  volume = {70},
  number = {8},
  pages = {823--834},
  doi = {10.1111/jir.70120}
}
Kostenlos starten →